Edwards Lifesciences Corp. buy Royal Bank of Canada
Start price
15.04.24
/
50%
€83.96
Target price
15.04.25
€95.04
Performance (%)
-4.50%
Price
29.04.24
€80.18
Summary
This prediction is currently active. With a performance of -4.50%, the BUY prediction for Edwards Lifesciences Corp. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 15.04.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Edwards Lifesciences Corp. | -1.812% |
iShares Core DAX® | 0.961% |
iShares Nasdaq 100 | 2.626% |
iShares Nikkei 225® | 0.217% |
iShares S&P 500 | 1.540% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Edwards Lifesciences Corp. diskutieren
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Royal Bank of Canada from $95.00 to $101.00. They now have an "outperform" rating on the stock.
Ratings data for EW provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€80.68
07.02.24
07.02.24
€88.24
07.02.25
07.02.25
-0.62%
29.04.24
29.04.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€67.68
12.01.24
12.01.24
€74.84
12.01.25
12.01.25
18.47%
29.04.24
29.04.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€60.38
26.10.23
26.10.23
€77.62
26.10.24
26.10.24
32.79%
29.04.24
29.04.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€71.40
17.08.23
17.08.23
€88.14
17.08.24
17.08.24
12.30%
29.04.24
29.04.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€74.66
01.08.23
01.08.23
€87.48
01.08.24
01.08.24
7.39%
29.04.24
29.04.24